8N Similar outcome in a randomized phase III trial comparing docetaxel versus vinorelbine both combined with trastuzumab as first line treatment for metastatic or locally advanced human epidermal growth factor receptor 2 (HER2) positive breast cancer
| Autor: | Andersson, M., Lidbrink, E., Wist, E., Enevoldsen, K., Jensen, A.B., Sørensen, P.G., Bjerre, K., Møller, S., Bergh, J., Langkjer, S.T. |
|---|---|
| Zdroj: | In EJC Supplements 2010 8(3):55-55 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect